임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
43건 표시
- 1상모집 예정· Pneumonia, Bacterial3회 기본 투여 후 12~15개월에 부스터 투여를 받는 영아의 시험용 폐렴구균 백신의 안전성 및 반응원성 평가 시험
A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose Primary Dosing Series Followed by a Booster Dose at 12 to 15 Months of Age
리드: GSK
- 3상모집 예정· Neoplasms, EndometrialA Study to Investigate GSK5733584 as Maintenance Treatment for Participants With MMRp Endometrial Cancer (BEHOLD-Endometrial02)
리드: GSK
- 2상모집 예정· Gastrointestinal NeoplasmsA Study of Velzatinib in Participants With Metastatic and/or Unresectable GIST After Imatinib, Sunitinib, Regorafenib, and Pimitespib
리드: GSK
- 4상모집 예정· Neoplasms, EndometrialA Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Primary Advanced or Recurrent Endometrial Cancer
리드: GSK
- 4상모집 예정· MyelofibrosisComparing Momelotinib and Ruxolitinib in People With Untreated Myelofibrosis and Low Blood Cell Counts
협력: GSK
- 2상모집 예정· Malaria, FalciparumA Phase 2A Study of a Novel Antimalarial Pyrrolidinamide in Adult Patients With Uncomplicated P. Falciparum Malaria
리드: GSK
- 3상모집 예정· Metabolic Dysfunction-associated SteatohepatitisA Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
리드: GSK
- 3상모집 예정· Metabolic Dysfunction-associated SteatohepatitisA Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
리드: GSK
- 1상모집 예정· Urinary Tract InfectionsA Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating Women
리드: GSK
- 1상모집 예정· Malaria, FalciparumDrug-Interaction Assessment of GSK3772701 in Healthy Male and Female Participants Aged 18 to 55 Years
리드: GSK
- 1/2상모집 예정· Lymphoma, Non-HodgkinA Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL
리드: GSK
- 1상모집 예정· Malaria, FalciparumFirst-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in Healthy Adults
리드: GSK
- 1상모집 예정· Kidney DiseaseA Study of GSK4771261 in Healthy Participants Aged 25 to 55 Years of Age Inclusive
리드: GSK
- 1상모집 예정· Urinary Tract InfectionsA Study in Pediatric Participants Aged ≥2 to <12 Years With a Suspected or Confirmed Bacterial Infection or Receiving Prophylaxis Antibiotics
리드: GSK
- 2상모집 예정· Locally Advanced Rectal Cancer (LARC)XELOX Plus DoSTARlimab Versus XELOX Alone as Consolidation Treatment After Standard Chemoradiation in pMMR/MSS or MSI-Low Locally Advanced Rectal Cancer (LARC) Patients
협력: GSK
- 2상모집 예정· DiarrhoeaLong-Term Immunogenicity of the altSonflex1-2-3 Shigella Vaccine in African Children
리드: GSK
- 2상모집 예정· MMRd/MSI-H Stage II-III Endometrial CancerClinical Trial to Assess the Efficacy of Dostarlimab as Neoadjuvant Therapy in Patients With MMRd/MSI-H Stage II-III Endometrial Cancer
협력: GSK
- 2상모집 예정· Endometrial CancerpReOperative Dostarlimab and Novel Therapies in EndOmetrial Cancer
협력: GSK
- 4상모집 예정· Neoplasms, EndometrialA Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)
리드: GSK
- 단계 미표기모집 예정· Tuberculosis, Multi Drug ResistantMolecular Epidemiology, Strains Genotyping of Multi-drug Resistant Tuberculosis Circulating in Central Africa Region
협력: GSK
- 단계 미표기모집 예정· Eosinophilic AsthmaEosinophil Subpopulations in Eosinophilic-associated Diseases
협력: GSK
- 1/2상모집 예정· Multiple MyelomaA Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory
협력: GSK
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.